Structural analysis of obscurin gene in hypertrophic cardiomyopathy

Takuro Arimura1, Yuji Matsumoto, Osamu Okazaki

  • 1Department of Molecular Pathogenesis, Medical Research Institute and Laboratory of Genome Diversity, School of Biomedical Science, Tokyo Medical and Dental University, 2-3-10 Kandasurugadai, Chiyoda-ku, Tokyo 101-0062, Japan.

Insights

Genetic mutations in the obscurin gene (OBSCN) may contribute to hypertrophic cardiomyopathy (HCM). A specific variant, Arg4344Gln, was found to disrupt obscurin

Area of Science:

  • Cardiovascular Genetics
  • Molecular Cardiology
  • Genetic Basis of Cardiac Diseases

Background:

  • Hypertrophic cardiomyopathy (HCM) is a genetic cardiac condition marked by left ventricular hypertrophy and diastolic dysfunction.
  • While mutations in sarcomere/Z-band protein genes explain about half of HCM cases, novel disease genes require identification.
  • Obscurin (OBSCN) interacts with titin/connectin, a known HCM-associated protein, making it a candidate for investigation.

Purpose of the Study:

  • To investigate the role of obscurin gene (OBSCN) mutations in the pathogenesis of hypertrophic cardiomyopathy (HCM).

Main Methods:

  • Screening of HCM patients for mutations in the obscurin gene (OBSCN).
  • Functional analysis of identified OBSCN variants, including Arg4344Gln and Ala4484Thr, focusing on titin/connectin binding and Z-band localization.
  • Utilizing Myc-tagged obscurin for assessing Z-band localization.

Main Results:

  • Two linked variants, Arg4344Gln and Ala4484Thr, were identified in an HCM patient.
  • The Arg4344Gln variant impaired the binding of obscurin to the Z9-Z10 domains of titin/connectin.
  • The Arg4344Gln variant also disrupted the proper localization of obscurin to the Z-band.

Conclusions:

  • Obscurin gene (OBSCN) abnormalities, particularly the Arg4344Gln variant, may play a role in the development of hypertrophic cardiomyopathy (HCM).
  • Disruption of obscurin-titin/connectin interaction and Z-band localization are potential mechanisms underlying HCM pathogenesis.
  • Further research into OBSCN as a causative gene for HCM is warranted.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Structure of Cardiac Muscles01:13

Structure of Cardiac Muscles

Cardiac muscle, or myocardium, is a specialized type of muscle found exclusively in the heart. Its unique structural and functional characteristics enable the heart to perform its vital role of pumping blood throughout the body continuously and rhythmically. The cardiac muscle cells, or cardiomyocytes, possess an endomysium and perimysium but do not have an epimysium.
Compared to skeletal muscles, cardiac muscle cells are small and mostly have a single nucleus. Additionally, they are usually...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...